BioSpace News Archive

Catalent, Inc. (NYSE: CTLT), the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, today announced the addition of three new members to its Board of Directors and the retirement of Board member James Quella after nine years of valued service.

The antiretroviral (ARV) will be immediately available in developing countries as a first-line regimen for people being treated for HIV/AIDS.

Albertsons Companies announced a definitive merger agreement under which privately held company will merge with publicly traded Rite Aid.

Nativis, Inc., a clinical-stage therapeutic device company developing non-sterile, non-invasive, non-thermal treatments for cancers and other serious diseases, announced it has received notice from the Food & Drug Administration (FDA) that the Nativis Voyager Pediatric system has been granted a Humanitarian Use Designation (HUD).

Scientists from Emulate and Roche form innovative partnership to use Organ-Chips for testing of efficacy and safety of new antibody therapeutics and combination therapies

The Gastroenterology Group, PC, a gastroenterology practice based in Reston, Va., announces its expansion into clinical research by partnering with Elligo Health Research.

NCCN Guidelines aim to improve quality, effectiveness and efficiency of cancer care. .

Infiniti Research has announced the completion of their latest list of the top medical devices companies in the world.

Cognate BioServices announced today it has completed a management buyout (“MBO”) and raised capital from a group of global investment firms.

Technavio has announced its newest market research report on the global foley catheters market for the period 2018-2022, providing the latest cutting-edge insights on this popular market.